Cargando…
Comparison of Genomic Profiling Data with Clinical Parameters: Implications for Breast Cancer Prognosis
SIMPLE SUMMARY: Around 20 years ago, genomic profiling of breast carcinomas identified tumor subtypes with clinical implications and opened the door for a better understanding of breast cancer biology. The commercialization of multigene tests had a significant impact on clinical practice, and yet, c...
Autores principales: | López-Ruiz, José A., Mieza, Jon A., Zabalza, Ignacio, Vivanco, María d. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454811/ https://www.ncbi.nlm.nih.gov/pubmed/36077734 http://dx.doi.org/10.3390/cancers14174197 |
Ejemplares similares
-
Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions
por: Iriondo, Oihana, et al.
Publicado: (2015) -
Sox2 promotes tamoxifen resistance in breast cancer cells
por: Piva, Marco, et al.
Publicado: (2014) -
Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature
por: Elorriaga, Miguel Ángel, et al.
Publicado: (2021) -
In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
por: Mazo, Claudia, et al.
Publicado: (2018) -
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
por: Domenici, Giacomo, et al.
Publicado: (2019)